A conjugate of the lytic peptide Hecate and gallic acid: structure, activity against cervical cancer, and toxicity

Aruoma OI, Murcia A, Butler J, Halliwell B (1993) Valuation of antioxidant and prooxidant actions of gallic acid and its derivatives. J Agric Food Chem 41:1880–1885 Asnaashari M, Farhoosh R, Sharif A (2014) Antioxidant activity of gallic acid and methyl gallate in triacylglycerols of Kilka fish oil and its oil-in-water emulsion. Food Chem 159:439–444. doi:10.1016/j.foodchem.2014.03.038 Baranska-Rybak W, Pikula M, Dawgul M, Kamysz W, Trzonkowski P, Roszkiewicz J (2013) Safety profile of antimicrobial peptides: camel, citropin, protegrin, temporin A and lipopeptide on HaCaT keratinocytes. Acta Pol Pharm 70:795–801 Barr SC, Rose D, Jaynes JM (1995) Activity of lytic peptides against intracellular Trypanosoma cruzi amastigotes in vitro and parasitemias in mice. J Parasitol 81:974–978 Barrajón-Catalán E, Menéndez-Gutiérrez MP, Falco A et al (2010) Selective death of human breast cancer cells by lytic immunoliposomes: correlation with their HER2 expression level. Cancer Lett 290:192–203. doi:10.1016/j.canlet.2009.09.010 Batista MN, Carneiro BM, Braga ACS, Rahal P (2014) Caffeine inhibits hepatitis C virus replication in vitro. Arch Virol. doi:10.1007/s00705-014-2302-1 Bernhaus A, Fritzer-Szekeres M, Grusch M et al (2009) Digalloylresveratrol, a new phenolic acid derivative induces apoptosis and cell cycle arrest in human HT-29 colon cancer cells. Cancer Lett 274:299–304. doi:10.1016/j.canlet.2008.09.020 Bodek G, Kowalczyk A, Waclawik A et al (2005) Targeted ablation of prostate carcinoma cells through LH receptor using hecate-CGβ conjugate: functional characteristic and molecular mechanism of cell death pathway. Exp Biol Med 230:421–428 Buolamwini JK (1999) Novel anticancer drug discovery. Curr Opin Chem Biol 3:500–509 Castro MS, Cilli EM, Fontes W (2006) Combinatorial synthesis and directed evolution applied to the production of α-helix forming antimicrobial peptides analogues. Curr Protein Pep Sci 7:473–478 Cespedes GF, Lorenzon EN, Vicente EF, Soares Mendes-Giannini MJ, Fontes W, Castro MS, Cilli EM (2012) Mechanism of action and relationship between structure and biological activity of Ctx-Ha: a new ceratotoxin-like peptide from Hypsiboas albopunctatus. Protein Pept Lett 19:596–603 Cilli EM, Pigossi FT, Crusca E et al (2007) Correlations between differences in amino-terminal sequences and different hemolytic activity of sticholysins. Toxicon 50:1201–1204. doi:10.1016/j.toxicon.2007.07.013 Cordova CAS, Locatelli C, Assunção LS et al (2011) Octyl and dodecyl gallates induce oxidative stress and apoptosis in a melanoma cell line. Toxicol Vitr 25:2025–2034. doi:10.1016/j.tiv.2011.08.003 Crusca E, Rezende AA, Marchetto R et al (2011) Influence of N-terminal modifications on the biological activity, membrane interaction, and secondary structure of the antimicrobial peptide hylin-a1. Biopolymers 96:41–48. doi:10.1002/bip.21454 Dathe M, Wieprecht T, Nikolenko H, Handel L, Maloy WL, MacDonald DL, Beyermann M, Bienert M (1997) Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and hemolytic activity of amphipathic helical peptides. FEBS Lett 403:208–212 Duncan R (2006) Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 6:688–701. doi:10.1038/nrc1958 Duval E, Zatylny C, Laurencin M, Baudy-Floc’h M, Henry J (2009) KKKKPLFGLFFGLF: a cationic peptide designed to exert antibacterial activity. Peptides 30:1608–1612 Eisenberg D, Weiss RM, Terwilliger TC (1984) The hydrophobic moment detects periodicity in protein hydrophobicity. Proc Natl Acad Sci USA 81:140–144 Ferlay J, Shin H-R, Bray F et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917 Fjell CD, Hiss JA, Hancock REW, Schneider G (2011) Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov. doi:10.1038/nrd3591 Gao X, Zhang X, Wang Y, Peng S, Fan C (2015) An in vitro study on the cytotoxicity of bismuth oxychloride nanosheets in human HaCaT keratinocytes. Food Chem Toxicol 80:52–61. doi:10.1016/j.fct.2015.02.018 Gaspar D, Veiga AS, Castanho MARB (2013) From antimicrobial to anticancer peptides: a review. Front Microbiol. doi:10.3389/fmicb.2013.00294 Gawronska B, Leuschner C, Enrigh F, Hansel W (2002) Effects of a lytic peptide conjugated to β hCG on ovarian cancer: studies in vitro and in vivo. Gynecol Oncol 85:45–52 Golubeva OY, Shamova OV, Orlov DS et al (2011) Synthesis and study of antimicrobial activity of bioconjugates of silver nanoparticles and endogenous antibiotics. Glass Phys Chem 37:78–84. doi:10.1134/S1087659611010056 Hansel W, Leuschner C, Gawronska B, Enright F (2001) Targeted destruction of prostate cancer cells and xenografts by lytic peptide-betaLH conjugates. Reprod Biol 1:20–32 Hansel W, Enright F, Leuschner C (2007a) Destruction of breast cancers and their metastases by lytic peptide conjugates in vitro and in vivo. Mol Cell Endocrinol 260–262:183–189. doi:10.1016/j.mce.2005.12.056 Hansel W, Leuschner C, Enright F (2007b) Conjugates of lytic peptides and LHRH or βCG target and cause necrosis of prostate cancers and metastases. Mol Cell Endocrinol 269:26–33 Henk WG, Todd WJ, Enright FM, Mitchell PS (1995) The morphological effects of two antimicrobial peptides, hecate-1 and melittin, on Escherichia coli. Scan Microsc 9:501–507 Hirata A, Nokihara K (2014) Construction of peptide-vehicles, bioconjugates having modules for cancer cell surface capture and cell-penetrating peptide with anticancer agents. Tetrahedron Lett 55:4091–4094. doi:10.1016/j.tetlet.2014.05.086 Ho H-H, Chang C-S, Ho W-C et al (2013) Gallic acid inhibits gastric cancer cells metastasis and invasive growth via increased expression of RhoB, downregulation of AKT/small GTPase signals and inhibition of NF-κB activity. Toxicol Appl Pharmacol 266:76–85. doi:10.1016/j.taap.2012.10.019 Howl J (2005) Peptide synthesis and applications, vol 31. Humana Press, Totowa Huang Y, Wang X, Wang H et al (2011) Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural framework. Mol Cancer Ther 10:416–426. doi:10.1158/1535-7163.mct-10-0811 Hudecz F (2005) Synthesis of peptide bioconjugates. Methods Mol Biol 298:209–223 Hurtado C, Bustos MJ, Sabina P, Nogal ML, Granja AG, González ME, Gónzalez-Porqué P, Revilla Y, Carrascosa AL (2008) Antiviral activity of lauryl gallate against animal viruses. Antvir Ther 13:909–917 Jamasbi E, Batinovic S, Sharples RA, Sani M-A, Robins-Browne RM, Wade JD, Separovic F, Hossain MA (2014) Melittin peptides exhibit different activity on different cells and model membranes. Amino Acids 46:2759–2766 Kee HJ, Cho S-N, Kim GR et al (2014) Gallic acid inhibits vascular calcification through the blockade of BMP2–Smad1/5/8 signaling pathway. Vasc Pharmacol 63:71–78. doi:10.1016/j.vph.2014.08.005 Kitagawa S, Nabekura T, Kamiyama S et al (2005) Effects of alkyl gallates on P-glycoprotein function. Biochem Pharmacol 70:1262–1266. doi:10.1016/j.bcp.2005.07.013 Ko T-C, Hour M-J, Lien J-C et al (2001) Synthesis of 4-alkoxy-2-phenylquinoline derivatives as potent antiplatelet agents. Bioorg Med Chem Lett 11:279–282 Korani MS, Farbood Y, Sarkaki A et al (2014) Protective effects of gallic acid against chronic cerebral hypoperfusion-induced cognitive deficit and brain oxidative damage in rats. Eur J Pharmacol 733:62–67. doi:10.1016/j.ejphar.2014.03.044 Kumar RV, Bhasker S (2014) Optimizing cervical cancer care in resource-constrained developing countries by tailoring community prevention and clinical management protocol. J Cancer Policy 2:63–73 Kumar CS, Leuschner C, Doomes EE et al (2004) Efficacy of lytic peptide-bound magnetite nanoparticles in destroying breast cancer cells. J Nanosci Nanotechnol 4:245–249 Lebedyeva IO, Ostrov DA, Neubert J et al (2014) Gabapentin hybrid peptides and bioconjugates. Bioorg Med Chem 22:1479–1486 Leuschner C, Enright FM, Gawronska B, Hansel W (2003) Membrane disrupting lytic peptide conjugates destroy hormone dependent and independent breast cancer cells. Breast Cancer Res Treat 78:17–27 Lorenzón EN, Sanches PRS, Nogueira LG et al (2013) Dimerization of aurein 1.2: effects in structure, antimicrobial activity and aggregation of Cândida albicans cells. Amino Acids 44:1521–1528. doi:10.1007/s00726-013-1475-3 Lutz J-F, Börner HG (2008) Modern trends in polymer bioconjugates design. Prog Polym Sci 33:1–39 Madlener S, Illmer C, Horvath Z et al (2007) Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells. Cancer Lett 245:156–162. doi:10.1016/j.canlet.2006.01.001 Merrifield RB (1963) Solid phase peptide synthesis 1: synthesis of a tetrapeptide. J Am Chem Soc 85:2149–2154 Mooney A, Corry AJ, O’Sullivan D et al (2009) The synthesis, structural characterization an in vitro anti-cancer activity of novel N-(3-ferrocenyl-2-naphthoyl) dipeptide ethyl esters and novel N-(6-ferrocenyl-2-naphthoyl) dipeptide ethyl esters. J Organomet Chem 694:886–894 Paredes-Gamero EJ, Martins MNC, Cappabianco FAM et al (2012) Characterization of dual effects induced by antimicrobial peptides: regulated cell death or membrane disruption. Biochim Biophys Acta 1820:1062–1072. doi:10.1016/j.bbagen.2012.02.015 Pelin M, Sosa S, Pacor S, Tubaro A, Florio C (2014) The marine toxin palytoxin induces necrotic death in HaCaT cells through a rapid mitochondrial damage. Toxicol Lett 229:440–450. doi:10.1016/j.toxlet.2014.07.022 Pennarun B, Gaidos G, Bucur O et al (2013) killerFLIP: a novel lytic peptide specifically inducing cancer cell death. Cell Death Dis 4:894. doi:10.1038/cddis.2013.401 Ran S, Downes A, Thorpe PE (2002) Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res 62:6132–6140 Rivero-Müller A, Vuorenoja S, Tuominen M et al (2007) Use of hecate–chorionic gonadotropin β conjugate in therapy of lutenizing hormone receptor expressing gonadal somatic cell tumors. Mol Cell Endocrinol 269:17–25. doi:10.1016/j.mce.2006.11.016 Rosés C, Carbajo D, Sanclimens G et al (2012) Cell-penetrating γ-peptide/antimicrobial undecapeptide conjugates with anticancer activity. Tetrahedron 68:4406–4412. doi:10.1016/j.tet.2012.02.003 Sarjit A, Wang Y, Dykes GA (2014) Antimicrobial activity of gallic acid against thermophilic Campylobacter is strain specific and associated with a loss of calcium ions. Food Microbiol 46:227–233. doi:10.1016/j.fm.2014.08.002 Shin SY, Lee SH, Yand ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI (2001) Antibacterial, antitumor and hemolytic activities of α-helical antibiotic peptide, P18 and its analogs. J Peptide Res 58:504–514 Slaninová J, Mlsorá V, Kroupová H, Alán L, Tunová T, Menicová L, Borovickova L, Fucík V, Cerovsky V (2012) Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cell. Peptides 33:18–26 Snider C, Jayasinghe S, Hristova K, White SH (2009) MPEx: a tool for exploring membrane proteins. Protein Sci 18:2624–2628 Spector AA, Yorek MA (1985) Membrane lipid composition and cellular function. J Lipid Res 26:1015–1035 Sun J, Li Y, Ding Y et al (2014) Neuroprotective effects of gallic acid against hypoxia/reoxygenation-induced mitochondrial dysfunctions in vitro and cerebral ischemia/reperfusion injury in vivo. Brain Res 1589:126–139. doi:10.1016/j.brainres.2014.09.039 Szakács G, Paterson JK, Ludwig JA et al (2006) Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5:219–234. doi:10.1038/nrd1984 Utsugi T, Schroit AJ, Connor J et al (1991) Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res 51:3062–3066 Vicente EF, Basso LGM, Cespedes GF et al (2013) Dynamics and conformational studies of TOAC spin labeled analogues of Ctx(Ile21)-Ha peptide from Hypsiboas albopunctatus. PLoS One. doi:10.1371/journal.pone.0060818 Vilar G, Tulla-Puche J, Alberício F (2012) Polymers and drug delivery systems. Curr Drug Deliv 9(4):367–394 Yang Q-Z, Wang C, Lang L et al (2013) Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa. Arch Pharm Res 36:1302–1310. doi:10.1007/s12272-013-0112-8 Yates C, Sharp S, Jones J et al (2011) LHRH-conjugated lytic peptides directly target prostate cancer cells. Biochem Pharmacol 81:104–110 You BR, Park WH (2010) Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase. Toxicol Vitr 24:1356–1362. doi:10.1016/j.tiv.2010.04.009 You BR, Moon HJ, Han YH, Park WH (2010) Gallic acid inhibits the growth of HeLa cervical cancer cells via apoptosis and/or necrosis. Food Chem Toxicol 48:1334–1340. doi:10.1016/j.fct.2010.02.034